Top

BMC Neurology

Published in:

Open Access 01-12-2021 | COVID-19 Vaccination | Case report

A case report of ChAdOx1 nCoV-19 vaccine–associated encephalitis

Authors: Junko Takata, Simon M. Durkin, Solomon Wong, Michael S. Zandi, Josephine K. Swanton, Tumena W. Corrah

Published in: BMC Neurology | Issue 1/2021

Abstract

Background

Vaccination against COVID-19 continues apace, but side-effects, both common and severe, continue to be reported. We report here the first published case of COVID-19 vaccine-related encephalitis.

Case presentation

A young woman presented with acute neuropsychiatric symptoms following recent ChAdOx1 nCoV-19 vaccination. Extensive investigation did not identify alternative causes.

Conclusions

This difficult case is here described, including presentation, investigation, and management. Further study on neuropsychiatric side-effects of COVID-19 vaccination, including investigation as to whether there may be a causal link, is required.

Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404. https://doi.org/10.1016/S1474-4422(15)00401-9.[published20February2016].CrossRefPubMedPubMedCentral

Shin Y-W, Lee S-T, Park K-I, et al. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord. 2017;11:1756285617722347. https://doi.org/10.1177/1756285617722347 ([published 16 August 2017]).CrossRefPubMedPubMedCentral

Wang H. Anti-NMDA receptor encephalitis and vaccination. Int J Mol Sci. 2017;18(1):193. https://doi.org/10.3390/ijms18010193 ([published 18 January 2017]).CrossRefPubMedCentral

Ross Russell A, Hardwick M, Jeyanantham A, et al. Spectrum, risk factors, and outcomes of neurological and psychiatric complications of COVID-19: A UK-wide cross-sectional surveillance study. SSRN [Preprint]. 24 June 2021 [cited 04 July 2021]. doi:1 0.2139/ssrn.3767901.

Siow I, Lee KS, Zhang JJY, et al. Encephalitis as a neurological complication of COVID-19: A systematic review and meta-analysis of incidence, outcomes, and predictors. Eur J Neurol. 2021;30(10):105863. https://doi.org/10.1111/ene.14913 (Published Online First 13 May 2021).CrossRef

Paterson RW, Benjamin LA, Mehta PR, et al. Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes. Brain Commun 2021:fcab099 [published 12 May 2021]. doi:https://doi.org/10.1093/braincomms/fcab099.

Lu L, Xiong W, Mu J, et al. The potential neurological effect of the COVID-19 vaccines: A review. Acta Neurol Scand. 2021;2021(144):3–12. https://doi.org/10.1111/ane.13417.CrossRef

Voysey M, Costa Clemens SA, Madhi SA, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881–91. https://doi.org/10.1016/S0140-6736(21)00432-3.Erratum.In:Lancet2021;397(10277):880.CrossRefPubMedPubMedCentral

UK Medicines and Healthcare Regulatory Agency (MHRA) 2021 COVID-19 AstraZeneca Vaccine Analysis Print, MHRA, https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/998492/COVID-19_AstraZeneca_Vaccine_Analysis_Print_DLP_23.06.2021.pdf (accessed 01 July 2021; updated 26 June 2021). 116pp.

10.

Butler M, Tamborska A, Wood GK, et al. Defining causality in neurological & neuropsychiatric COVID-19 vaccine complications: What have we learnt from current and previous vaccination campaigns? SSRN [Preprint]. 9 April 2021 [cited 04 July 2021]. doi https://doi.org/10.2139/ssrn.3823441

11.

Anon. Claims and counterclaims over alleged adverse reaction in covid-19 vaccine in India. BMJ. 2020;371:m4734. https://doi.org/10.1136/bmj.m4734.CrossRef

12.

Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–27. https://doi.org/10.1016/S2215-0366(21)00084-5 ([published 6 April 2021]).CrossRefPubMedPubMedCentral

Title: A case report of ChAdOx1 nCoV-19 vaccine–associated encephalitis
Authors: Junko Takata
Simon M. Durkin
Solomon Wong
Michael S. Zandi
Josephine K. Swanton
Tumena W. Corrah
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: COVID-19 Vaccination
Vaccination
SARS-CoV-2
COVID-19
Encephalitis
Encephalopathy
Published in: BMC Neurology / Issue 1/2021
Electronic ISSN: 1471-2377
DOI: https://doi.org/10.1186/s12883-021-02517-w

2024 ASCO Annual Meeting

Springer Medicine

A case report of ChAdOx1 nCoV-19 vaccine–associated encephalitis

Abstract

Background

Case presentation

Conclusions

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Paraneoplastic sensorimotor neuropathy and ventral cauda equina nerve root enhancement as initial presentation of small cell lung carcinoma: a case study

The long‐term outcome of neuropsychological function is favorable in patients with non‐malignancy related anti-GABABR encephalitis: a case series

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis

The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review

Study protocol: effect of infection, Modic and inflammation on clinical outcomes in surgery for radiculopathy (EIMICOR)

Meningitis as a recurrent manifestation of anti-AQP4/anti-MOG negative neuromyelitis optica spectrum disorder: a case report